NE

NeuroLeap Capital

VC
New York, NYWebsite
How to approach: cold outreach ok
Stage

Pre-Seed, Seed

Check Size

$300K – $2.5M

Portfolio

3+ companies

Team

2 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

An emerging fund investing in mental health and neuroscience-focused AI platforms for workplaces.

Meet the Team

DS

David Sloan

Founder & GP

Neuroscience
HR Analytics
KB

Kumaar Bagrodia

Founder, Applied Neuroscientist

Applied Neuroscience
Brain-Computer Interface
Mental Health Enhancement

Industry Focus

Invests In

Other
Healthcare
AI / ML
Developer Tools

Does Not Invest In

EdTech

Portfolio Companies (3)

Other

EM

EmotionAI Labs

Healthcare AI
WE

WellMetrics

Mental Health Analytics
NE

NeuroLeap

Neuroscience / Mental Health / Brain Performance·Angel

"Discovered via openai_search (medium confidence)"

A health-tech / neuroscience company using brain-computer interface (BCI) technology for brain enhancement and mental health.

Browse More Investors

Frequently Asked Questions

See if NeuroLeap Capital is a match for your startup

Upload your pitch deck to see how well you match with NeuroLeap Capital and 200+ other VC firms.